. Author manuscript; available in PMC: 2020 Sep 17.

Published in final edited form as: Cancer Lett. 2015 Nov 12;370(2):324–331. doi: 10.1016/j.canlet.2015.11.005

Table 4.

Mutations detected in tumor tissue DNA only of discordant samples.

Patient no.	Cancer type	Tumor stage	Position	Gene	Mutation (amino acid change)	Mutation type	% Mutation: tumor (reads)	% Mutation: plasma (reads)	% Mutation: WBC (reads)
35	AC	IV	chr17:37880981	ERBB2	p.E770delinsEAYVM	INS	12.0 (1908)	0.0 (9552)	0.0 (258)
53	AC	IV	chr17:7578440	TP53	p.K125X	SNP	53.5 (2110)	0.0 (21288)	0.0 (1298)
53	AC	IV	chr7:55259524	EGFR	p.L861Q	SNP	32.2 (14941)	0.0 (10934)	0.0 (879)
75	AC	IIIA	chr17:7577141	TP53	p.G227E	SNP	11.7 (1683)	0.0 (9551)	0.0 (890)
75	AC	IIIA	chr7:55242469	EGFR	p.747_753del	DEL	49.5 (9795)	0.0 (46146)	0.0 (6804)
78	AC	IIIA	chr17:7577610	TP53	Intronic	SNP	18.2 (1994)	0.0 (76927)	0.0 (13409)
78	AC	IIIA	chr17:7578457	TP53	p.R119L	SNP	5.9 (11563)	0.0 (43503)	0.0 (13732)
90	AC	IIIA	chr7:55241708	EGFR	p.G719A	SNP	82.4 (17241)	0.0 (66562)	0.0 (2049)

AC: adenocarcinoma; SNP: single nucleotide polymorphism; DEL: deletion; INS: insert.